北京中医药大学学报2024，Vol.47Issue(6)：760-764,5.DOI:10.3969/j.issn.1006-2157.2024.06.004
"中医状态"纵向视域下方证相应理论内涵新释
New interpretation of the theoretical connotation of the correspondence between prescription and syndrome from the longitudinal perspective of"traditional Chinese medicine state"
摘要
Abstract
The correspondence between prescription and syndrome is the advantage and characteristic of traditional Chinese medicine(TCM)treatment.However,the pathogenesis of clinical diseases is complex and the condition is changeable,and the clinical application is difficult to achieve the maximum effect under the existing cognition of the correspondence between prescription and syndrome.In this paper,the five categories of physiological characteristics,pathological characteristics,constitution,syndrome,and disease of the longitudinal classification of"TCM state"are introduced into the correspondence of prescription and syndrome.Under the vertical perspective of"TCM state",the theoretical connotation of the correspondence between prescription and syndrome is interpreted as"correspondence between prescription and state",namely correspondence of"prescription-physiological characteristics",correspondence of"prescription-pathological characteristics",correspondence of"prescription-constitution",correspondence of"prescription-syndrome",and correspondence of"prescription-disease".It is hoped to accurately grasp the corresponding connotation of the correspondence between prescription and syndrome,in order to deepen the clinical thinking mode of TCM.关键词
方证相应/中医状态/方态相应Key words
correspondence between prescription and syndrome/traditional Chinese medicine state/correspondence between prescription and state分类
医药卫生引用本文复制引用
乔世杰,林多多,张少栋,雷黄伟,王洋,李灿东,付超,蔡姿尧,唐文,王章林,王志斌,童康,李明珠,韩海瑞.."中医状态"纵向视域下方证相应理论内涵新释[J].北京中医药大学学报,2024,47(6):760-764,5.基金项目
国家中医药管理局第二届全国名中医传承工作室建设项目(国中医药办人教函[2022]245号) The Second National Famous Traditional Chinese Medicine Inheritance Studio Construction Project of the State Administration of Traditional Chinese Medicine(No.[2022]245) （国中医药办人教函[2022]245号）
